Last updated on June 2019

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)


Brief description of study

This study will determine the dose-response relationship of VAY736 for key efficacy and safety parameters

Clinical Study Identifier: NCT02962895

Find a site near you

Start Over

Novartis Investigative Site

Almada, Portugal
0.38miles
  Connect »

Novartis Investigative Site

Lisboa, Portugal
4.64miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.